Why Navidea Biopharmaceuticals Shares Are Nosediving
Why Navidea Biopharmaceuticals Shares Are Nosediving
If Navidea Biopharmaceuticals Inc (NASDAQ:NAVB) shares are trading lower by 18.5% to $0.08 after the company announced NYSE American has commenced delisting proceedings and the company intends to appeal.
Navidea 生物制药公司 纳斯达克股票代码：NAVB）宣布后，股价下跌18.5％，至0.08美元 纽约证券交易所美国分所 已启动除牌程序，该公司打算提出上诉。
Navidea's Board of Directors plans to appeal the decision. During the appeal, the common stock will continue to be listed and traded on NYSE American.
Navidea董事会计划对该决定提出上诉。在上诉期间，普通股将继续在纽约美国证券交易所上市和交易。
The company says there can be no assurance that Navidea's request for continued listing will be granted.
该公司表示，无法保证Navidea的继续上市请求会获得批准。
If delisted, Navidea intends to quote its common stock in the over-the-counter market.
如果退市，Navidea打算在场外交易市场报价其普通股。
See Also: Why AerCap Shares Are Rising Today
另见：为什么 AerCap 的股价今天上涨
According to data from Benzinga Pro, NAVB has a 52-week high of $0.65 and a 52-week low of $0.07.
根据Benzinga Pro的数据，NAVB创下52周高点为0.65美元，52周低点为0.07美元。
